Better 20 Year Implant Survivorship with Ceramic-on-Ceramic vs Metal-on-Polyethylene Bearing in THA .
This report has been verified
by one or more authors of the
original publication.
Ceramic-on-ceramic total hip arthroplasty is superior to metal-on-conventional polyethylene at 20-year follow-up: A randomised clinical trial
Orthop Traumatol Surg Res. 2021 Feb;107(1): 102744.One hundred and sixteen patients (140 hips) scheduled for a primary total hip arthroplasty (THA) were randomized to receive a ceramic-on-ceramic (alumina) bearing (n=71 hips) or a metal-on-conventional polyethylene bearing (n=69 hips). The outcomes of interest included implant survivorship, measured by the aseptic revision rate and Kaplan Meier survivorship estimator, the mean time to aseptic revision, the incidence of osteolytic signs, the incidence of adverse events, Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index scores, and Joint Perception scores. Outcomes were assessed at 20 years post-operation. Results revealed statistically significantly favourable aseptic revision rates (3% vs 25%, p<0.001), Kaplan Meier survivorship (96.9% vs 73.6%, p<0.001), and WOMAC scores (11.0 vs 19.4, p=0.048) in the ceramic bearing group compared to the metal bearing group. Moreover, the incidence of periarticular osteolytic signs was statistically significantly lower in the ceramic bearing group compared to the metal bearing group (6.1% vs 60.9%, p<0.001). Finally, the mean time to aseptic revision was 12.9 years in the metal bearing group and 11.5 years in the ceramic bearing group. In addition, 3 cases of dislocation were observed in the metal bearing group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
